Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
11°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Chemours Company
(NY:
CC
)
21.94
+0.41 (+1.90%)
Official Closing Price
Updated: 7:00 PM EST, Nov 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Chemours Company
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Upgrades
Via
Benzinga
Chemours (CC) Q3 2022 Earnings Call Transcript
October 26, 2022
CC earnings call for the period ending September 30, 2022.
Via
The Motley Fool
The Chemours Company Reports Third Quarter 2022 Results
October 25, 2022
From
The Chemours Company
Via
Business Wire
Earnings Scheduled For October 25, 2022
October 25, 2022
Companies Reporting Before The Bell • UBS Gr (NYSE:UBS) is expected to report earnings for its third quarter. • SAP (NYSE:SAP) is expected to report earnings for its third quarter.
Via
Benzinga
Analyst Ratings for Chemours
October 13, 2022
Chemours (NYSE:CC) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Chemours Announces Fourth Quarter Dividend
October 25, 2022
From
The Chemours Company
Via
Business Wire
Chemours and the University of Delaware Unveil the Center for Clean Hydrogen
October 19, 2022
From
The Chemours Company
Via
Business Wire
Chemours Begins Operation of Trail Ridge South Mineral Sand Mine in Florida
October 17, 2022
From
The Chemours Company
Via
Business Wire
Expert Ratings for Chemours
September 23, 2022
Analysts have provided the following ratings for Chemours (NYSE:CC) within the last quarter:
Via
Benzinga
3 Undervalued Cruise Stocks to Buy Now
August 16, 2022
These undervalued cruise stocks have bounced back exceedingly well from the pandemic-led weakness and are benefitting from pent-up demand.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
October 13, 2022
Upgrades
Via
Benzinga
Chemours Announces Joint Venture Agreement with BWT to Enable the Capacity and Innovation Required by the Transportation Fuel Cell Market
October 10, 2022
From
The Chemours Company
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2022
October 05, 2022
Upgrades
Via
Benzinga
Chemours Announces Dates for Third Quarter 2022 Earnings Release and Webcast Conference Call
October 04, 2022
From
The Chemours Company
Via
Business Wire
Chemours Announces $200 Million Investment to Expand Capacity and Technology in Response to Growing Global Demand for Hydrogen Solutions
October 03, 2022
From
The Chemours Company
Via
Business Wire
McDonald's Price Target Cut By This Analyst, Plus Cowen Predicts $362 For Domino's Pizza
September 27, 2022
Citigroup cut McDonald's Corporation (NYSE: MCD) price target from $275 to $246. McDonald's shares rose 0.5% to $245.00 in pre-market trading.
Via
Benzinga
Spero Therapeutics To Rally Around 240%? Plus This Analyst Slashes PT On Salesforce
September 23, 2022
Evercore ISI Group raised the price target on Spero Therapeutics, Inc. (NASDAQ: SPRO) from $2 to $8. Evercore ISI Group analyst Josh Schimmer also upgraded the stock from In-Line to Outperform. Spero...
Via
Benzinga
UnitedHealth To Rally 24%? Here Are 5 Other Price Target Changes For Thursday
September 22, 2022
Raymond James raised the price target on UnitedHealth Group Incorporated (NYSE: UNH) from $620 to $635. Raymond James analyst John Ransom maintained the stock with a Strong Buy rating. UnitedHealth...
Via
Benzinga
Chemours Commends the U.S. Senate for Ratification of the Kigali Amendment
September 22, 2022
From
The Chemours Company
Via
Business Wire
Chemours, Alcoa And Other Big Losers From Wednesday
September 22, 2022
U.S. stocks closed lower with the Dow Jones dropping more than 500 points on Tuesday. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
The Chemours Company Provides Update on Full Year 2022 Guidance
September 21, 2022
From
The Chemours Company
Via
Business Wire
Chemours Washington Works Awards Four Local Students with Scholarships
September 14, 2022
From
The Chemours Company
Via
Business Wire
Chemours Titanium Technologies Announces Second Annual Carrier of the Year Award
September 08, 2022
From
The Chemours Company
Via
Business Wire
West Virginia State University and Chemours Partner to Advance Chemistry and Chemical Engineering Education
August 24, 2022
From
The Chemours Company and West Virginia State University
Via
Business Wire
The Chemours Company Announces Promotion of Kristine Wellman to Senior Vice President, General Counsel & Corporate Secretary, as Dave Shelton Announces Retirement and Moves to Role as Special Counsel to the CEO
August 22, 2022
From
The Chemours Company
Via
Business Wire
Chemours Begins Commissioning at Its Newest Sand Mine in Clay County, Florida
August 16, 2022
From
The Chemours Company
Via
Business Wire
Chemours Details Progress in its Fifth Corporate Responsibility Commitment Report
August 09, 2022
From
The Chemours Company
Via
Business Wire
Chemours Takes the Next Step in its ESG and Sustainability Journey; Commits to Set Science-Based Emissions Reduction Targets
August 05, 2022
From
The Chemours Company
Via
Business Wire
UBS Maintains Neutral Rating for Chemours: Here's What You Need To Know
July 29, 2022
UBS has decided to maintain its Neutral rating of Chemours (NYSE:CC) and raise its price target from $35.00 to $37.00. Shares of Chemours are trading up 3.55% over the last 24 hours, at $36.14 per...
Via
Benzinga
5 Analysts Have This to Say About Chemours
July 29, 2022
Over the past 3 months, 5 analysts have published their opinion on Chemours (NYSE:CC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's...
Via
Benzinga
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.